Home›Stocks›KMTS

KMTS — structural market context

Kestra Medical Technologies, L

Structural market context from public regulatory and market data, shown with its as-of dates. Descriptive only: nothing on this page is a recommendation, a prediction, or advice to buy or sell any security.

What changed

As of the close on Nov 2. Each line shows the earlier value, the later value and their dates.

Price

Change from the Oct 30 close to the Nov 2 close: +0.40%.

Volume

1.01× its 20-session average on Nov 2.

Includes pre- and post-market trading.

Short interest

Short interest 3.4M shares (settlement Oct 15) vs 3.3M (Sep 30).

No new file loaded in this window. Latest file: settlement Oct 15, loaded Oct 27.

Fails-to-deliver

Latest file (settlements Sep 15–Sep 30, published Oct 16): 11 days with fails, largest 29K shares on Sep 21.

Previous file (settlements Sep 1–Sep 14, published Sep 30): 5 days with fails, largest 3K shares on Sep 11.

No new file loaded in this window.

Analyst rating actions

None recorded in this window.

Insider filings (Form 4)

None recorded in this window.

KMTS events and their magnitude

Latest SEC filing in the event study

Form 4 · other · filed 2026-10-29 · View on sec.gov ↗

…

How the Event Study works →

KMTS short interest & days to cover

SHARES SHORT
3.4M
% OF FLOAT
10.2%
DAYS TO COVER
12.3
CHANGE VS PRIOR
+4.6%

FINRA consolidated short interest, reported twice a month and published ~2 weeks after each settlement date. % of float uses reported free float. · as of 2026-10-15 (19d ago)

How short interest and days to cover are measured →

KMTS fails-to-deliver (FTD)

Settlement dateFailed sharesPrice
2026-09-30 · 34d13K$28.46
2026-09-29 · 35d5K$28.13
2026-09-28 · 36d476$27.14

SEC fails-to-deliver files, published twice a month with ~6 weeks of delay.

How fails-to-deliver are reported →

KMTS insider buying and selling (Form 4)

Last 12 months, Form 4 codes P and S: 0 purchases · 15 sales

InsiderTypeSharesValueFiled
Mahboob Vaseem · officer: Chief Financial OfficerSale (S)35K$1.0M2026-10-29
Umberger Traci S · director, officer: See RemarksSale (S)30K$901K2026-10-29
Mahboob Vaseem · officer: Chief Financial OfficerSale (S)5K$147K2026-10-29
Mahboob Vaseem · officer: Chief Financial OfficerSale (S)40K$1.2M2026-10-29
Umberger Traci S · director, officer: See RemarksSale (S)96K$2.6M2026-10-22

SEC Form 4 filings: purchases and sales reported on Form 4 (transaction codes P and S) only; grants and option exercises excluded. Attributed public records.

Form 4 transaction codes explained →

KMTS offering filings (SEC)

3 SEC filings in the last 12 months, none in the last 90 days. The most recent: Automatic shelf registration statement (Form S-3ASR) S-3ASR, filed 2026-04-01. View on sec.gov ↗

SEC filings listed by filing date. A registration statement or prospectus does not by itself show that any shares were sold, how many, or at what price. Some of these filings cover debt securities or resales by existing holders. A filing is made by the issuer and appears under each of its tickers. Source: SEC EDGAR daily index; each filing links to its page on sec.gov.

Offering registration and prospectus filings (S-1, S-3, F-1 and F-3 with their amendments, S-3ASR, F-3ASR, 424B4 and 424B5) on SEC EDGAR in the last 12 months, each counted once.

SEC offering filings explained →

KMTS analyst ratings

FirmActionRatingPublished
Evercore ISIinitialiseOutperform2026-10-20
Evercore ISIprice_target—2026-10-20
Piper SandlerholdOverweight2026-09-15
RBC Capitalprice_target—2026-09-15

Rating actions as published by the firms, from public feeds. They are not graded here.

Frequently asked questions

What is KMTS's short interest?
As of the FINRA settlement date 2026-10-15, KMTS had 3.4M shares sold short — 10.2% of its float, with 12.3 days to cover at average volume. FINRA publishes this data roughly two weeks after each twice-monthly settlement, so it is inherently delayed. A short-interest figure describes an aggregate position; it does not predict what the stock will do.
Are insiders buying KMTS?
In the last 12 months of SEC Form 4 filings, KMTS recorded 0 insider purchases and 15 sales reported on Form 4 (transaction codes P and S; grants and option exercises excluded). These are attributed public records — information, not instruction.
What are the SEC offering filings listed for KMTS?
They are registration statements (Forms S-1, S-3, F-1 and F-3, with their amendments and the S-3ASR and F-3ASR automatic shelf forms) and prospectuses filed under Rule 424(b)(4) or 424(b)(5). In the last 12 months the issuer of KMTS filed 3; the most recent was a automatic shelf registration statement (Form S-3ASR) on 2026-04-01. A registration statement or prospectus does not by itself show that any shares were sold, how many, or at what price, and some of these filings cover debt securities or resales by existing holders.
What do analysts say about KMTS?
The most recent action: Evercore ISI initialise to Outperform on 2026-10-20. Rating actions are shown as published by the firms; they are not graded here.
Is this page telling me to buy or sell KMTS?
No. Everything on this page is descriptive, structural market context from public data, shown with its as-of dates. TradeAI News does not issue directional recommendations, price predictions, or buy/sell advice — for any ticker.
All covered stocksShort Interest & FTD trackerInsider Buying trackerThe platform

Other companies in the same SEC industry: Surgical & Medical Instruments & Apparatus

BBNX · Beta Bionics, Inc.BSX · Boston Scientific Corp.KIDS · OrthoPediatrics Corp.LUNG · Pulmonx CorporationSOLV · Solventum CorporationBDX · Becton, Dickinson and Co.

Industry: SIC code 3841 as recorded on SEC EDGAR.

All tickers starting with K →

KMTS: the full history

Latest rows shown. Full history, market-wide screens, cluster detection and the context journal live in the dashboard.

Start free →View plans →

Not financial advice. Trading involves risk. Descriptive structural context, never a recommendation.

Sign up with Google or emailCreate a free account